360O_PR - developmental therapeutics Phase I study of the pan-fibroblast growth factor receptor (FGFR) inhibitor BAY 1163877 with expansion cohorts for subjects based on tumor FGFR mRNA expression levels
| Autor: | Joerger, M., Soo, R., Cho, B.C., Mendivil, A. Navarro, Sayehli, C., Richly, H., Tai, D., Kim, D.-W., Wolf, J., Cassier, P., Ellinghaus, P., Hildebrandt, S., Behre, S., Helmbrecht, C., Kerpen, S., Zielinski, D., Ince, S., Rajagopalan, P., Ocker, M., Schuler, M. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi558-vi558 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|